MLYS Next Earnings Date Notes

— Mineralys Therapeutics (NASDAQ: MLYS) is a clinical-stage biopharmaceutical company focused on developing therapies for hypertension & related cardiorenal diseases. Their lead product candidate, lorundrostat, is a novel, highly selective aldosterone synthase inhibitor currently being evaluated in Phase 2 clinical trials for uncontrolled & resistant hypertension—conditions with significant unmet medical need. When monitoring MLYS's long-term performance, investors should pay close attention to clinical trial progress and data readouts, especially efficacy & safety results for lorundrostat, as the company's future hinges on successful trial outcomes and regulatory milestones. Other critical business metrics include cash runway, R&D expenditures, and updates regarding potential partnerships or licensing deals. Financial disclosures regarding operating costs & cash position are key, since Mineralys does not currently generate revenue. On the upcoming earnings call, it will be especially important to listen for commentary on trial timelines, enrollment updates, regulatory interactions, and strategic priorities—these factors will drive both the company's valuation & overall success in bringing their pipeline to market. The next projected earnings date for MLYS is 8/11/2026 after close (stay tuned for a confirmed earnings date once announced).

MLYS Next Earnings Date FAQ

On this page we presented the MLYS Next Earnings Date information for Mineralys Therapeutics along with recent past earnings dates. For Q1 of 2026, MLYS reported earnings of -0.470/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, MLYS reported earnings of -0.400/share, with the earnings report taking place on 3/12/2026. For Q3 of 2025, MLYS reported earnings of -0.520/share, with the earnings report taking place on 11/10/2025. For Q2 of 2025, MLYS reported earnings of -0.660/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, MLYS reported earnings of -0.790/share, with the earnings report taking place on 5/12/2025. Based on these past earnings dates, the projected next earnings date for MLYS is 8/11/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Mineralys Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Mineralys Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Mineralys Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next MLYS earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up MLYS's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the MLYS next earnings date.